glp-1 drugs and menopause Microdosing for Perimenopause Menopause: A Hormone-Aware Metabolic Framework GLP-1 Medications and Their Role
Description
Additionally, lixisenatide was associated with fewer gastrointestinal symptoms compared to exenatide, while long-acting GLP-1RAs generally caused less nausea and vomiting but more diarrhea than short-acting agents ( 4.4 Metabolic effects GLP-1RA are emerging as highly versatile drugs, as their unraveling features now adds to a broader potential in future

Alternatives of GLP-1s Below are all of our articles for you to learn about GLP-1s

Several factors should be considered such as magnitude of HbA1c reduction, effect on weight loss and adverse effect rate (34)
"While further research is needed, liraglutide may work through various mechanisms, such as reducing inflammation in the brain, lowering insulin resistance and the toxic effects of Alzheimer's biomarkers amyloid-beta and tau, and improving how the brain's nerve cells communicate." One thing liraglutide didn't appear to do for the patients in this trial was meaningfully improve their brain's glucose metabolism, which is another key part of dementia progression

Real-World vs

The brain has been rewired by substances, so something else needs to rewire it again